Predictive Oncology Stock Price Prediction
| POAI Stock | USD 0.72 0.03 4.35% |
Oversold Vs Overbought
55
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth (0.43) |
Using Predictive Oncology hype-based prediction, you can estimate the value of Predictive Oncology from the perspective of Predictive Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Predictive Oncology to buy its stock at a price that has no basis in reality. In that case, they are not buying Predictive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Predictive Oncology after-hype prediction price | USD 0.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Predictive |
Predictive Oncology After-Hype Price Prediction Density Analysis
As far as predicting the price of Predictive Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Predictive Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Predictive Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Predictive Oncology Estimiated After-Hype Price Volatility
In the context of predicting Predictive Oncology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Predictive Oncology's historical news coverage. Predictive Oncology's after-hype downside and upside margins for the prediction period are 0.04 and 6.41, respectively. We have considered Predictive Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Predictive Oncology is dangerous at this time. Analysis and calculation of next after-hype price of Predictive Oncology is based on 3 months time horizon.
Predictive Oncology Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Predictive Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Predictive Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Predictive Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 5.70 | 0.01 | 0.01 | 4 Events / Month | 4 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.72 | 0.71 | 1.39 |
|
Predictive Oncology Hype Timeline
Predictive Oncology is at this time traded for 0.72. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Predictive is forecasted to decline in value after the next headline, with the price expected to drop to 0.71. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.39%, whereas the daily expected return is at this time at -0.19%. The volatility of related hype on Predictive Oncology is about 7434.78%, with the expected price after the next announcement by competition of 0.71. The book value of the company was at this time reported as 2.04. The company recorded a loss per share of 2.96. Predictive Oncology last dividend was issued on the 29th of October 2019. The entity had 1:20 split on the 24th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 4 days. Check out Predictive Oncology Basic Forecasting Models to cross-verify your projections.Predictive Oncology Related Hype Analysis
Having access to credible news sources related to Predictive Oncology's direct competition is more important than ever and may enhance your ability to predict Predictive Oncology's future price movements. Getting to know how Predictive Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Predictive Oncology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BEAT | Heartbeam | (0.27) | 7 per month | 3.32 | 0.06 | 10.30 | (6.23) | 22.69 | |
| EUDA | EUDA Health Holdings | 0.07 | 2 per month | 6.74 | 0.01 | 9.70 | (10.50) | 26.33 | |
| NUTX | Nutex Health | (0.42) | 9 per month | 5.30 | 0.10 | 11.28 | (9.19) | 47.75 | |
| HCTI | Healthcare Triangle | 0.01 | 3 per month | 8.22 | 0.11 | 10.34 | (17.65) | 131.09 | |
| MGRX | Mangoceuticals, Common Stock | 0.16 | 7 per month | 0.00 | (0.11) | 7.29 | (10.11) | 37.65 | |
| ACON | Aclarion | (0.01) | 7 per month | 0.00 | (0.05) | 11.11 | (10.00) | 35.83 |
Predictive Oncology Additional Predictive Modules
Most predictive techniques to examine Predictive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Predictive using various technical indicators. When you analyze Predictive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Predictive Oncology Predictive Indicators
The successful prediction of Predictive Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Predictive Oncology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Predictive Oncology based on analysis of Predictive Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Predictive Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Predictive Oncology's related companies. | 2021 | 2022 | 2024 (projected) | Payables Turnover | 0.48 | 0.54 | 0.31 | Days Of Inventory On Hand | 290.55 | 311.08 | 387.01 |
Story Coverage note for Predictive Oncology
The number of cover stories for Predictive Oncology depends on current market conditions and Predictive Oncology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Predictive Oncology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Predictive Oncology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Predictive Oncology Short Properties
Predictive Oncology's future price predictability will typically decrease when Predictive Oncology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Predictive Oncology often depends not only on the future outlook of the potential Predictive Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Predictive Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4 M | |
| Cash And Short Term Investments | 8.7 M |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |